Celestica to Hold Q3 2024 Financial Results Conference Call and Virtual Investor Meeting Wednesday, October 23, 2024

October 7, 2024

TORONTO, Oct. 07, 2024 (GLOBE NEWSWIRE) — Celestica’s third quarter financial results conference call and virtual investor meeting will take place on Wednesday, October 23. The conference call start time is 5:00pm ET. Financial results will be released after market close. During the investor meeting, Celestica’s management will provide an overview of the business, growth opportunities and its financial outlook.

Participants are invited to join the live webcast at the following link.

For those unable to participate, a recorded webcast will be available approximately two hours after completion of the call. To access the recorded webcast visit www.celestica.com.

Contact

Celestica Investor Relations
[email protected]

Hot this week

Topics

Popular Categories

News RoomFeatured CompaniesVideos

Launch Two Acquisition Corp. Announces the Pricing of $200,000,000 Initial Public Offering

Hammond Power Solutions Completes Asset Purchase of Micron Industries Corporation

Celestica to Hold Q3 2024 Financial Results Conference Call and Virtual Investor Meeting Wednesday, October 23, 2024

Suspended trading due to challenges with NAV calculations

Result of the auction of 2.25 per cent DGB 2026 and 2.25 per cent DGB 2033 G

Pharma Equity Group’s subsidiary (Reponex Pharmaceuticals A/S) has obtained patent protection in Japan for the treatment of colorectal cancer with RNX-051.

Man Group PLC : Form 8.3 – Centamin plc

trivago Welcomes Global Icon Jürgen Klopp as Brand Ambassador in New AI-Powered Marketing Campaign

Topics

Suspended trading due to challenges with NAV calculations

Result of the auction of 2.25 per cent DGB 2026 and 2.25 per cent DGB 2033 G

Pharma Equity Group’s subsidiary (Reponex Pharmaceuticals A/S) has obtained patent protection in Japan for the treatment of colorectal cancer with RNX-051.

Man Group PLC : Form 8.3 – Centamin plc

trivago Welcomes Global Icon Jürgen Klopp as Brand Ambassador in New AI-Powered Marketing Campaign

Man Group PLC : Form 8.3 – AngloGold Ashanti plc

Breakdown of debtors, Realkredit Danmark A/S

WithSecure to host an Investor Day on 22 November 2024

Related Articles

Suspended trading due to challenges with NAV calculations

Result of the auction of 2.25 per cent DGB 2026 and 2.25 per cent DGB 2033 G

Pharma Equity Group’s subsidiary (Reponex Pharmaceuticals A/S) has obtained patent protection in Japan for the treatment of colorectal cancer with RNX-051.

Man Group PLC : Form 8.3 – Centamin plc

trivago Welcomes Global Icon Jürgen Klopp as Brand Ambassador in New AI-Powered Marketing Campaign

Company

Headlines

Suspended trading due to challenges with NAV calculations

Result of the auction of 2.25 per cent DGB 2026 and 2.25 per cent DGB 2033 G

Pharma Equity Group’s subsidiary (Reponex Pharmaceuticals A/S) has obtained patent protection in Japan for the treatment of colorectal cancer with RNX-051.

Man Group PLC : Form 8.3 – Centamin plc

Newsletter